Skip to main content


Figure 2 | BMC Medical Research Methodology

Figure 2

From: Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysis

Figure 2

Risk-benefit planes showing the joint incremental risk and benefit of anticoagulants used for venous thromboembolism prophylaxis in orthopedic surgery. The figure shows separate analyses for patients receiving ximelagatran (A), low molecular weight heparin (B), Unfractionated heparin (C), warfarin (D) and fondaparinux (E). The dashed line corresponds to the reference value for the risk benefit acceptability threshold.

Back to article page